Effects of second generation tetracyclines on penicillin-epilepsy-induced hippocampal neuronal loss and motor incoordination in rats

Life Sciences

Volumn 79, Issue 8, 2006, Pages 784-790

  Yilmaz, Ismail ^a   Adiguzel, Esat ^a   Akdogan, Ilgaz ^a   Kaya, Ertugrul ^a   Hatip Al Khatib, Izzettin ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Doxycycline; Hippocampus; Minocycline; Neuronal cell count; Penicillin epilepsy; Rotarod

Indexed keywords

DOXYCYCLINE; MINOCYCLINE; PENICILLIN G; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL COUNT; CELL LOSS; CONTROLLED STUDY; COORDINATION DISORDER; DRUG EFFECT; EPILEPSY; HIPPOCAMPUS; MALE; MOTOR COORDINATION; NONHUMAN; RAT; ROTAROD TEST; TASK PERFORMANCE;

ANIMALS; ATAXIA; CELL COUNT; DOXYCYCLINE; EPILEPSY; HIPPOCAMPUS; MALE; MINOCYCLINE; NEURONS; NEUROPROTECTIVE AGENTS; PENICILLIN G; RATS; ROTAROD PERFORMANCE TEST;

EID: 33745517298     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.02.027     Document Type: Article

References (59)

1. Adiguzel E., Akdogan I., Duzcan S.E., and Tufan A.C. Effect of penicillin induced epilepsy seizure on granulare cell layer of dentate gyrus in rat: a stereological study. Neuroscience Research Communications 31 (2002) 101-119
2. Adiguzel E., Duzcan S.E., Akdogan I., and Tufan A.C. A simple low-cost method for two dimensional microscopic measuring and stepping on the microscopic plate. Neuroanatomy 2 (2003) 6-8
3. Akdogan I., Unal N., and Adiguzel E. Estimation of the number of neurons in the hippocampus of rats with penicillin induced epilepsy. Image Analysis and Stereology 21 (2002) 117-120
4. Amin A.R., Attur M.G., Thakker G.D., Patel P.D., Vyas P.R., Patel R.N., Patel I.R., and Abramson S.B. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases. Proceedings of the National Academy of Sciences of the United States of America 93 (1996) 14014-14019
5. Auer R.N., and Siesjö B.K. Biological differences between ischemia, hypoglycemia, and epilepsy. Annals of Neurology 24 (1988) 699-707
6. Avoli M., Brancati A., Pacitti C., and Barra P.F. Neuronal responses to putative neurotransmitters during penicillin epileptogenesis. Neuroscience 7 (1982) 1955-1961
7. Baptiste D.C., Hartwick A.T., Jollimore C.A., Baldridge W.H., Seigel G.M., and Kelly M.E. An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Molecular Pharmacology 66 (2004) 1113-1122
8. Berry M., Bannister L.H., and Standring S.M. Nervous system. In: Williams P.L. (Ed). Gray's Anatomy. 38th edition (1995), Churchill Livingstone, New York 901-1399
9. Brundula V., Rewcastle N.B., Metz L.M., Bernard C.C., and Yong V.W. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 125 (2002) 1297-1308
10. Castanares M., Vera Y., Erkkila K., Kyttanen S., Lue Y., Dunkel L., Wang C., Swerdloff R.S., and Hikim A.P. Minocycline up-regulates BCL-2 levels in mitochondria and attenuates male germ cell apoptosis. Biochemical and Biophysical Research Communications 337 (2005) 663-669
11. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., Bian J., Guo L., Farrell L.A., Hersch S.M., Hobbs W., Vonsattel J.P., Cha J.H., and Friedlander R.M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington's disease. Nature Medicine 6 (2000) 797-801
12. Chen X., Sheng C., and Zheng X. Direct nitric oxide imaging in cultured hippocampal neurons with diaminoanthraquinone and confocal microscopy. Cell Biology International 25 (2001) 593-598
13. Choi S.H., Lee D.Y., Chung E.S., Hong Y.B., Kim S.U., and Jin B.K. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. Journal of Neurochemistry 95 (2005) 1755-1765
14. Clarck D.L., and Boutros N.N. Limbic system: temporal lobe. Chapter 11, Hippocampal Formation. The Brain and Behavior (1999), Blackwell Science, Massachusetts 146 pp.
15. Cornet S., Spinnewyn B., Delaflotte S., Charnet C., Roubert V., Favre C., Hider H., Chabrier P.E., and Auguet M. Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline. European Journal of Pharmacology 505 (2004) 111-119
16. Cunha B.A., Comer J.B., and Jonas M. The tetracyclines. Medical Clinics of North America 66 (1982) 293-302
17. Diguet E., Gross C.E., Tison F., and Bezard E. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results. Experimental Neurology 189 (2004) 1-4
18. Dökmeci D., Al-Khatib İ., Karadaǧ Ç.H., and Ulugöl A. The effect of Lavandula stoechas growing in Turkey on convulsion produced by various methods in mice. The Journal of School of Medicine of Trakya University 11 (1994) 53-61
19. Domercq M., and Matute C. Neuroprotection by tetracyclines. Trends in Pharmacological Sciences 25 (2004) 609-612
20. Du Y., Ma Z., Lin S., Dodel R.C., Gao F., Bales K.R., Triarhou L.C., Chernet E., Perry K.W., Nelson D.L., Luecke S., Phebus L.A., Bymaster F.P., and Paul S.M. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 14669-14674
21. Dunham N.W., and Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. Journal of the American Pharmaceutical Association 46 (1957) 208-209
22. El-Yamany N.A., and Horn E. Time courses of aspartate and glutamate concentrations in the focus area during penicillin induced epileptiform activity in awake rats. Archives Italiennes de Biologie 140 (2002) 13-30
23. Familian A., Boshuizen R.S., Eikelenboom P., and Veerhuis R. Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation. Glia 53 (2006) 233-240 (Electronic publication ahead of print)
24. Fisher R.S. Animal models of the epilepsies. Brain Research Reviews 14 (1989) 245-278
25. Goni-Allo B., Ramos M., Jordan J., and Aguirre N. In vivo studies on the protective role of minocycline against excitotoxicity caused by malonate or N-methyl-d-aspartate. Experimental Neurology 191 (2005) 326-330
26. He Y., Appel S., and Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Research 909 (2001) 187-193
27. Horn E., Esseling K., and Weber R. Protective sensitivity changes of the motor cortex due to epileptiform experience of the visual cortex. Pharmacology, Biochemistry and Behavior 44 (1993) 709-715
28. Hunter C.L., Quintero E.M., Gilstrap L., Bhat N.R., and Granholm A.C. Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. European Journal of Neuroscience 19 (2004) 3305-3316
29. Jankowsky J.L., and Patterson P.H. The role of cytokines and growth factors in seizures and their sequelae. Progress in Neurobiology 63 (2001) 125-149
30. Kapusnik-Uner J.E., Sande M.A., and Chambers H.F. Tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In: Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., and Gilman A.G. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th edition (1996), Macmillan Publishing, New York 1123-1130
31. Korkmaz A., and Tumkaya L. Estimation of the section thickness and optical dissector height with a simple calibration method. Journal of Microscopy 187 (1997) 104-109
32. Kraus R.L., Pasiecznyi R., Lariosa-Willinghami K., Turneri M.S., Jiangi A., and Traugeri J.W. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. Journal of Neurochemistry 94 (2005) 819-827
33. Lin S., Wei X., Xu Y., Yan C., Dodel R., Zhang Y., Liu J., Klaunig J.E., Farlow M., and Du Y. Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons. Life Sciences 72 (2003) 1635-1641
34. Loeb C., Patrone A., Besio G., Balestrino M., and Mainardi P. The excitatory amino acid antagonist amino-phosphono-valeric acid (APV) provides protection against penicillin-induced epileptic activity in the rat. Epilepsy Research 3 (1990) 249-251
35. Lu W., Chen G., and Cheng J.S. NMDA antagonist displays anticonvulsant effect via NO synthesis inhibition in penicillin-treated rat hippocampal slices. NeuroReport 9 (1998) 4045-4049
36. Morimoto N., Shimazawa M., Yamashima T., Nagai H., and Hara H. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Research 1044 (2005) 8-15
37. Munzar P., Li H., Nicholson K.L., Wiley J.L., and Balster R.L. Enhancement of the discriminative stimulus effects of phencyclidine by the tetracycline antibiotics doxycycline and minocycline in rats. Psychopharmacology 160 (2002) 331-336
38. Narkilahti S., Pirttilla T.J., Lukasiuk K., Tuunanen J., and Pitkanen A. Expression and activation of caspase 3 following status epilepticus in the rat. European Journal of Neuroscience 18 (2003) 1486-1496
39. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic Press, San Diego
40. Pi R., Li W., Lee N.T., Chan H.H., Pu Y., Chan L.N., Sucher N.J., Chang D.C., Li M., and Han Y. Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. Journal of Neurochemistry 91 (2004) 1219-1230
41. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., and Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Annals of Neurology 51 (2002) 215-223
42. Proper E.A., Hoogland G., van Veelen C.W.M., and de Graan P.N.E. Morphological changes in the human epileptogenic hippocampus. Neuroscience Research Communications 3 (2001) 129-146
43. Sanchez Mejia R.O., Ona V.O., Li M., and Friedlander R.M. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48 (2001) 1393-1399
44. Shen E.Y., and Lai Y.J. In vivo microdialysis study of excitatory and inhibitory amino acid levels in the hippocampus following penicillin-induced seizures in mature rats. Acta Paediatrica Taiwanica 43 (2002) 313-318
45. Smith D.L., Woodman B., Mahal A., Sathasivam K., Ghazi-Noori S., Lowden P.A.S., Bates G.P., and Hockly E. Minocycline and doxycycline are not beneficial in a model of Huntington's disease. Annals of Neurology 4 (2003) 186-196
46. Suk K. Minocycline suppresses hypoxic activation of rodent microglia in culture. Neuroscience Letters 366 (2004) 167-171
47. Teng Y.D., Choi H., Onario R.C., Zhu S., Desilets F.C., Lan S., Woodard E.J., Snyder E.Y., Eichler M.E., and Friedlander R.M. Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America 101 (2004) 3071-3076
48. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-d-aspartate neurotoxicity by inhibiting microglia. Journal of Immunology 166 (2001) 7527-7533
49. Tomas-Camardiel M., Rite I., Herrera A.J., de Pablos R.M., Cano J., Machado A., and Venero J.L. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiology of Disease 16 (2004) 190-201
50. Tooyama I., Bellier J.P., Park M., Minnasch P., Uemura S., Hisano T., Iwami M., Aimi Y., Yasuhara O., and Kimura H. Morphologic study of neuronal death, glial activation, and progenitor cell division in the hippocampus of rat models of epilepsy. Epilepsia 43 (2002) 39-43
51. Wang X., Zhu S., Drozda M., Zhang W., Stavrovskaya I.G., Gattaneo E., Ferrante R.J., Kristal B.S., and Friedlander R.M. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proceedings of the National Academy of Sciences of the United States of America 100 (2003) 10483-10487
52. Wells J.E., Hulbert R.J., Fehlings M.G., and Yong V.W. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126 (2003) 1628-1637
53. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anatomical Record 231 (1991) 482-497
54. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., and Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. Journal of Neuroscience 22 (2002) 1763-1771
55. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., and Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 15769-15774
56. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 13496-13500
57. Zeng Y.C., Pezzola A., De Carolis A.S., and Sagratella S. Inhibitory influence of morphinans on ictal and interictal EEG changes induced by cortical application of penicillin in rabbits: A comparative study with NMDA antagonists and pentobarbitone. Pharmacology, Biochemistry and Behavior 43 (1992) 651-656
58. Zhang W., Narayanan M., and Friedlander R.M. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Annals of Neurology 53 (2003) 267-270
59. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu du C., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome-c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78